December 7, 2022

Abata Therapeutics Appoints Ellen Cahir-McFarland, Ph.D., as Chief Scientific Officer

Abata in the News

Abata Therapeutics to Participate in Guggenheim’s 4th Annual Immunology and Neurology Day  

Press Release
November 9, 2022

Samantha Singer Named as 2022 PharmaVoice 100 Honoree

September 8, 2022

Abata Therapeutics to Present at Upcoming September Investor Conferences

Press Release
August 31, 2022

Abata Therapeutics to Participate in the Guggenheim I&I Spotlight Series – Treg-Based Therapies

Press Release
July 7, 2022

Abata Therapeutics to Present at Upcoming Investor Conferences

Press Release
June 2, 2022

Abata Therapeutics Appoints Sandy Lazzari as Chief People Officer

Press Release
April 28, 2022

Abata Announces Formation of Advisory Board Comprised of Leading Industry Experts in Treg Biology, Cell Therapy and Corporate Development

Press Release
April 6, 2022

Does It Matter Where You Locate Your Biopharma Anymore?

Life Science Leader
December 3, 2021

Treg engineers take aim at autoimmunity

Nature Biotechnology
November 9, 2021

Abata Therapeutics Strengthens Board of Directors

Press Release
July 28, 2021